• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    An apparatus, system, and method for contacting blood with ozone to kill microorganisms in the blood is described. The method involves injecting microbubbles of ozone containing gas into a flow of blood at a temperature of less than 12°C. The apparatus includes a blood flow conduit including a blood ozone contacting portion including a porous ozone injector.Figure to be published with the abstract: Fig. 1
    公开号:SE1451072A1
    申请号:SE1451072
    申请日:2014-09-15
    公开日:2016-03-16
    发明作者:Johan Sjöholm
    申请人:Johan Sjöholm；
    IPC主号:
    专利说明:

    1 TITLE: Apparatus and method for contacting blood with ozone Field of the Invention The present invention relates to methods and apparatus for treating biological fluids with ozone. More particularly, the invention relates to methods and apparatus for treating blood with ozone.
    Background of the Invention 1 0Ozone is a strong oxidizing agent that has been used as a disinfectant. Despite the corrosive and highly reactive nature of ozone, the use of ozone to kill or inactivate certain infectious agents in blood has been explored. For example, US 2005/0189302 Al discloses a method of inactivating viruses in blood by exposing the blood to ozone in a gas-fluid contacting device that maximizes gas-fluid mass transfer. The contacting device contains spheres or rods to form a thin film of blood and treatment is preferably performed at ambient temperature. WO 2011/162805 A2 discloses methods for inactivating infectious prion proteins in blood by subjecting blood to an ozone/oxygen admixture using a gas-fluid contacting device similar to that disclosed in US 2005/0189302 Al.
    WO 93/15779 Al discloses a method of increasing the nitric oxide concentration in the blood by contacting a sample of blood with ozone gas and ultraviolet radiation. The treated sample of blood is administered to a patient to treat a variety of conditions including bacterial, fungal, viral, and protozoal infection. The blood sample is most preferably a volume of 1 to 50 mL and is most preferably treated at a temperature of 42.5°C for approximately 3 minutes.
    US 6,027,688 discloses a method for inactivating viruses, bacteria, fungi and protozoa in blood by contacting a flow of blood with counter-flow of an ozone-oxygen mixture for about 16 seconds using a gas-liquid contact apparatus.
    Treating milk and other liquid foodstuffs with ozone to kill bacteria is known. WO 2008/066470 discloses a method for inhibiting bacterial growth in milk by exposing the milk to a finely divided gas stream containing ozone at ambient temperature.
    While ozone has been used for stimulating the immune system by treating small amounts of blood and returning the treated blood to a patient, such treatments rely on an activation of the immune system to kill the vast majority of microbes in the blood of the patient. Although ozone has been used for killing microbes in large volumes of dairy products, such methods would destroy blood cells and inactivate enzymes and other proteins in the blood. 2 There is a need for methods and apparatus to treat and prevent serious bacterial, fungal, and viral infections that are not susceptible to treatment by conventional means such as antibiotic, antifungal, and antiviral drugs. Although ozone is known to kill microbes in blood, previously described methods do not provide adequate microbe killing without damaging the blood. Thus, there is a need for apparatus and methods for ozonating blood in a way that kills microbes in the blood of a patient without damaging blood cells or interfering with the normal function of blood in the patient. Related apparatus and method may also be used to ozonate blood before and/or after storage to kill microbes in the blood before storage and/or administration to a patient. Human and nonhuman animal patients suffering, for example, from microbial infection in the blood would benefit from such apparatus and methods, particularly in cases where convention drug therapy is not effective. Hence, an improved system, apparatus, and method for contacting blood with ozone would be advantageous.
    Summary of the Invention Embodiments of the present invention preferably seek to mitigate, alleviate or eliminate one or more deficiencies, disadvantages or issues in the art, such as the above-identified, singly or in any combination by providing an apparatus for contacting blood with ozone, an ozonation system comprising the apparatus, and a method for contacting blood 2 0with ozone, according to the appended patent claims. While the invention is described with respect to the ozonation of blood and contacting blood with ozone, the invention is applicable to the ozonation of other biological fluids such as blood plasma, blood cell suspensions, and suspensions of other cell types.
    According to one aspect of the invention, an ozonation apparatus for contacting blood with ozone is provided. The apparatus comprises an ozone injector adapted to inject microbubbles of ozone containing gas into a flow of blood in an ozonation zone of an ozone contacting chamber, or ozonation chamber. The apparatus may optionally comprise means for cooling blood entering the ozonation chamber and/or means for warming blood exiting the ozonation chamber.
    According to another aspect of the invention, a blood ozonation system is provided.
    The system comprises the ozonation apparatus, a source of ozone connected to the ozone injector, conduits for receiving blood into and delivering blood from the apparatus, and pumping means for pumping blood through the system. The system optionally comprises cooling means for cooling the blood before entering the ozonation apparatus and/or warming means for warming ozonated blood leaving the ozonation apparatus.
    According to yet another aspect of the invention, a method for contacting blood with ozone is provided. The method involves contacting blood with micro-sized bubbles of a gas 3 containing ozone. The blood is at a temperature of less than 12°C when contacted with the microbubbles, the microbubbles have a mean diameter of less than 5 jim.
    According to yet another aspect of the invention, a method for contacting blood with ozone is provided. The method involves receiving blood, cooling the blood to a temperature of less than 12°C, contacting the chilled blood with microbubbles of a gas containing ozone, optionally warming the blood to a warmed temperature, and delivering the blood to a storage container or storage vessel.
    According to yet another aspect of the invention, a method for treating a patient suffering from microbial infection is provided. The method involves receiving blood from the 1 0patient, cooling the blood to a temperature of less than 12°C, contacting the chilled blood with microbubbles of a gas containing ozone, warming the blood, and returning the blood to the patient. The method is advantageously performed using the system or apparatus of the invention.
    Further embodiments of the invention are defined in the dependent claims, wherein features for the second and subsequent aspects of the invention are as for the first aspect mutatis mutandis.
    Unless otherwise defined, all terms used herein, including technical and scientific terms, have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. It will be further understood that terms, such as those defined 2 0in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
    The term "microorganism" as used herein is synonymous with "microbe" and means any microorganism including bacteria, virus, fungi or yeast, and including spores or dormant forms of such a microorganisms.
    The term "comprises/comprising" when used in this specification is taken to specify the presence of stated features, integers, steps or components but does not preclude the presence or addition of one or more other features, integers, steps, components or groups thereof. The indefinite articles "a" and "an" as used herein, unless clearly indicated to the 3 0contrary, should be understood to mean "at least one."The phrase "and/or" as used herein should be understood to mean "either or both" of the elements so conjoined, i.e., elements that are conjunctively present in some cases and disjunctively present in other cases. Multiple elements listed with "and/or" should be construed in the same fashion, i.e., "one or more" of the elements so conjoined. Other elements may optionally be present other than the elements specifically identified by the "and/or" clause, whether related or unrelated to those elements specifically identified. Thus, as a non-limiting example, a reference to "A and/or B", when used in conjunction with open-ended language such as "comprising" can 4 refer, in one embodiment, to A only (optionally including elements other than B); in another embodiment, to B only (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); etc. As used herein, "or" should be understood to have the same meaning as "and/or" as defined above. For example, when separating items in a list, "or" or "and/or" shall be interpreted as being inclusive, i.e., the inclusion of at least one, but also including more than one, of a number or list of elements, and, optionally, additional unlisted items. Only terms clearly indicated to the contrary, such as "only one of' or "exactly one of," or, when used in the claims, "consisting of," will refer to the inclusion of exactly one element of a number or list of elements. In general, the term "or" as used herein shall only be interpreted as indicating exclusive alternatives (i.e. "one or the other but not both") when preceded by terms of exclusivity, such as "either," "one of," "only one of," or "exactly one of." "Consisting essentially of," when used in the claims, shall have its ordinary meaning as used in the field of patent law.
    As used herein in the specification and in the claims, the phrase "at least one," in reference to a list of one or more elements, should be understood to mean at least one element selected from any one or more of the elements in the list of elements, but not necessarily including at least one of each and every element specifically listed within the list of elements and not excluding any combinations of elements in the list of elements.
    Brief Description of the Drawings These and other aspects, features and advantages of which embodiments of the invention are capable of will be apparent and elucidated from the following description of embodiments of the present invention, reference being made to the accompanying drawings, in which Fig. 1 is a schematic of a first embodiment of an ozonation system comprising an apparatus for contacting blood with ozone.
    Fig. 2 is a schematic of a second embodiment of an ozonation system comprising an apparatus for contacting blood with ozone.
    Fig. 3 is a flow chart of method steps for a method for contacting blood with ozone.
    Description of embodiments Specific embodiments of the invention now will be described with reference to the accompanying drawings. This invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein; rather, these embodiments are provided so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. The terminology used in the detailed description of the embodiments illustrated in the accompanying drawings is not intended to be limiting of the invention. In the drawings, like numbers refer to like elements. A first embodiment of an ozonation system according to the invention is shown in Fig. 1. The apparatus comprises an ozonation apparatus (1) comprising an ozonation chamber (2) comprising an inlet (2a) and an outlet (2b), and an ozone injector (3). The ozone injector (3) is configured to be connected to a source of ozone gas (4), such as an ozone generator that produces ozone from oxygen that may produce a gas mixture that contains, for example, from 5% to 20% ozone and from 80% to 95% oxygen. The porous material of the ozone injector may be made, for example, from sintered stainless steel or a sintered ceramic having a uniform mean pore size of less than 5jim in diameter, such as 4Rm, 3Rm, 211m, 1 Jim, 0.511m, or 0.211rn and preferably a pore size that is between about 0.21.tm and about 2.0 pm. The ozone gas injector (3) may further comprises a flow meter, pressure valve, pressure sensor, and/or controlling element to facilitate monitoring and/or control the pressure and/or flow rate of gas being injected.
    The embodiment shown in Fig. 1 shows an ozonation apparatus (1) comprising a porous cylindrical ozone injector (3) inside a cylindrical ozonation chamber (2) that is configured to guide a flow of blood around the porous microbubble releasing surface of the ozone injector (3). A gap exists between the inner wall of the ozonation chamber (2) and the porous microbubble releasing surface of the ozone injector (3). The flow of blood over the 2 0microbubble releasing surface is preferably a laminar flow to minimize turbulence in the blood flow and the blood flow is preferably vertically upwards so that gas microbubbles entrain in the flow of blood. The shape of the ozone injector (3) need not be cylindrical and not all surfaces of the ozone injector need to be in contact with blood. One alternative configuration is shown in Fig. 2.
    The ozone injector (3) is configured in the ozonation chamber (2) such that blood flow is restricted to pass through ozonation chamber (2) within a maximum distance (d) of a porous surface of the ozone injector (3) from which microbubbles are released. The maximum distance (d) is preferably less than about 2mm, such as 1.5mm, 1.0mm, 0.75mm, 0.5mm, 0.25mm, or 0.1mm or any distance within this range. When blood and ozone containing gas are flowing through the ozonation chamber (1), an ozonation region (5), indicated as the region between the horizontal dashed lines in Fig. 1, exists in which microbubbles are entrained in the blood flow and are dissolved in the blood. The ozonation chamber (2) and ozone injector (3) are designed to provide an ozonation zone (5) in which micrometer sized bubbles of ozone containing gas mix with and dissolve in a flow of blood. 3The duration of ozone contacting time, or dwell time, is determined by a number of factors including the concentration of ozone in the gas, the flow rate of the gas, the temperature of the blood, and the flow rate of the blood, any or all of which may be computer controlled by 6 controlling gas pressure and flow from the source of ozone (4), and the operation of blood pumping means (10) and optionally blood cooling means (11).
    A system according to the present invention may comprise more than one ozonation apparatus. For example, a plurality of ozone apparatus may be arranged in parallel with respect to the flow of blood. It is also possible to configure a single ozone apparatus to comprise a plurality of ozone injectors arranged such that all blood moving through the ozonation chamber passes within the maximum distance (d) of at least one of the ozone injectors.
    The ozonation system shown in Fig. 1 additionally comprises blood pumping means 1 0(10) for pumping blood through the system from a blood inlet portion (8) to a blood outlet portion (9). Pumping means (10) for pumping blood are known in the art and may comprise, for example, a peristaltic pump, a roller pump, or a centrifugal pump. Pumping means (10) may be capable of pumping blood through the system at a suitable flow rate, for example from about 0.1 Liters/hour to about 12 Liters/hour.
    The system may also comprise an ozone source (4), such as a medical grade ozone generator, connected to the ozone injector (3) by a gas conduit (6), which may comprise a one-way valve (7) to prevent backf low of blood into the ozone generator (6) in case of, for example, a sudden pressure drop in the gas conduit (6). The ozone source (4) is preferably capable of delivering at least 10% ozone at a constant pressure so that the pressure of gas is at least 0.1 bar and preferably up to 0.5 bar, 0.75 bar or 1.0 bar at the ozone injector (3).
    The system may additionally comprise a source of one or more inert gasses that may be mixed with the ozone containing gas before reaching the ozone injector. Examples of inert gasses include nitrogen and helium.
    The blood contacting portions of the system may be made of any suitable materials typically used to transfer or store blood, such as those used in tubing for transfusions or blood conducting portions of heart and lung machine or apheresis machines. The blood entry portion (2) may comprise or be connectable to means for receiving blood from a patient such as a hollow needle for insertion in to a vein. Alternatively or additionally, blood entry portion (2) may comprise means for receiving blood from a container of blood such as bag or 3 0bottle or an extracorporeal blood circulation device such as an apheresis machine, dialysis machine, or heart and lunch machine.
    The ozonation system may comprise blood cooling means (11) positioned upstream of ozonation apparatus inlet (2a) and configured to cool the blood to a chilled temperature of less than 12°C before the blood enters the ozonation apparatus (1). The blood cooling means (11) may comprise any suitable blood heat exchanger used in the medical arts to cool blood and may be configured for computer control of the temperature of the blood entering the ozonation chamber (2). The blood cooling means (11) is preferably controllable to cool 7 said blood to a temperature of between about 4°C and about 12°C, to produce chilled blood that is contacted with ozone containing gas in the ozonation chamber (2).
    Additionally or alternatively, the ozonation system may comprise blood warming means (12) positioned downstream of the outlet (2b) from the ozonation apparatus (1) and configured to warm ozonated blood to a temperature above the blood temperature in the ozonation chamber (2). The blood warming means (12) may be configured to warm blood to a body temperature of a human or nonhuman animal, e.g. between about 24°C to about 39°C. Blood warming means (12) may additionally or alternatively be configured to adjust the temperature of the blood to a storage temperature. Blood warming means (12) may be computer controlled similarly to blood cooling means (11).
    The system may comprise a blood processing unit (13) comprising means for removing bubbles, foam, thrombi, and/or other material that must be removed before the blood can be delivered to a patient or storage container. Blood processing unit (13) may comprise, for example, a filter for removing particles and/or a blood reservoir comprising an inlet region separated from an outlet region by a membrane that is permeable for blood, but impermeable for air bubbles. A blood processing unit (13) may be particularly useful in embodiments of the invention used to ozonate blood that is to be delivered to a patient.
    All or parts of the apparatus and/or system may be combined with and/or controlled by a computerized control system (19) that may be electrically coupled to sensors, actuators, valves, and/or switches in the ozonation system. The control system (19) may comprise software having code segments configured to control operational parameters of the apparatus, such as blood and gas flow rates and pressures, the concentration of ozone and other gasses in the ozone containing gas, blood temperature in the different portions of the apparatus, and blood flow rates in various portions of the apparatus and/or system conduit based upon sensor data received from pressure, flow, temperature, and/or chemical sensors provided in various portions of the apparatus.
    Fig. 2 shows an embodiment of an ozonation system comprising an alternatively configured ozonation apparatus (1). Only the top surface of the ozone injector (3) is in contact with blood and injects microbubbles of ozone containing gas into a flow of blood that 3 0entrains the injected microbubbles. An ozonation region (5) is located directly above the ozone injector (3) in which the microbubbles completely dissolve in the blood. Without intending to be bound by theory, it is believed that the ozone is also entirely consumed by chemical reactions with the blood within the ozonation region (5). The ozonation chamber (2) is configured such that all of the blood flow passes within a maximum distance (d) from the upper surface of the ozone injector (3). The maximum distance (d) is preferably less than about 2mm, such as 1.5mm, 1.0mm, 0.75mm, 0.5mm, 0.25mm, or 0.1mm or any distance within this range. Alternatively, the diameter of blood flow can be narrowed above 8 the ozone injector (3) such that a flow of blood entrains a flow of microbubbles in an ozonation zone (5) above the injector. With such an embodiment, the maximum distance from the surface of the ozone injector (3) may be greater and the diameter of the flow in the ozonation zone (5) is preferably less than about 2mm, such as 1.5mm, 1.0mm, 0.75mm, 0.5mm, 0.25mm, or 0.1mm or any distance within this range.
    In one aspect, the present invention relates to a method for contacting blood with ozone (Fig. 3). In a first embodiment, the method comprises receiving a flow of blood (301) into an ozonation system; injecting microbubbles of ozone containing gas (303) into the flow of blood; and delivering the ozonated blood from the system (305) wherein the blood is at a 1 0temperature of less than 12°C during the injecting of ozone and the microbubbles have a mean diameter of less than 5 jim. In preferred embodiments, the temperature of the blood during ozone injection is between about 4°C and about 10°C, such as 5°C, 6°C, 7°C, 8°C, or 9°C. The ozone containing gas is normally produced by an ozone generator that produces a mixture of ozone and oxygen comprising between 5% and 20% ozone. The concentration of ozone in the ozone containing gas injected into the flow of blood is preferably less than grams/m3 and more preferably less than 5 grams/m3. Preferably, the concentration of ozone in the ozone containing gas is at least 1 gram/m3 and the pressure of gas being injected may be for example, at least 0.1 bar and preferably up to 0.5 bar, 0.75 bar or 1.0. The ratio of the volumetric flow rate of blood and the volumetric flow rate of ozone containing gas may be adjusted to be in a range of from about 10:1to about 50:1. The volumetric flow rate of blood may be in the range of from 0.1 Liters/hour to 12 Liters/hour, for example 3 Liters/hour to 6 Liters/hour. The delivered dose of ozone in the blood flow is less than 10 ppm, and may be for example, 1 ppm, 2 ppm, 3 ppm, 4 ppm, 5 ppm, 6 ppm, 7 ppm, 8 ppm, or 9 ppm. The flow of blood is preferably a laminar flow to minimize turbulence and the flow rates and pressures are controlled or set such that the microbubbles have a uniform mean diameter of less than 5Rrn in diameter and completely dissolve in the flow of blood in less than 10 seconds, preferably less than 5 seconds, and more preferably less than 2 seconds. Controlling the flow and pressure of the ozone containing gas and blood flow rate in this way can prevent the microbubbles from coalescing into larger bubbles so that essentially all of the 30microbubbles entrained in the blood flow have the desired diameter.
    If the method is to be performed on blood from a patient or other source of blood that has a temperature higher than the ozonation temperature, the method may further comprise cooling the blood (302) before ozone is injected into the flow of blood (303). If the blood is to be returned to a patient or stored at a temperature above the ozonation 3temperature, the blood may be warmed (304) before being delivered from the system (305).
    If the ozonated blood is to be stored, warming the blood may not be necessary. The flow of blood received into the ozonation system may optionally be pretreated (301a). For example, 9 an anticoagulant or other drug may be added to the blood flow. Extracorporeal treatment of blood introduces the risk of bubble formation, blood foaming, and the formation of clots or precipitates. The method may therefore include one or more post treatment processing steps (304a) to remove foam, bubbles, clots, and/or precipitates.
    Blood ozone contacting time and temperature may be optimized for killing particular microorganisms, or microbes. The contacting may be comprise the administration of drugs that may have an additive or synergistic effect with the ozone to kill microbes and/or a protective effect to reduce unwanted or adverse effects associated with contacting blood with an ozone containing gas.
    The present invention has been described above with reference to specific embodiments. However, other embodiments than the above described are equally possible within the scope of the invention. Different method steps than those described above, performing the method by hardware or software, may be provided within the scope of the invention. The different features and steps of the invention may be combined in other combinations than those described. The scope of the invention is only limited by the appended patent claims.
    While several embodiments of the present invention have been described and illustrated herein, those of ordinary skill in the art will readily envision a variety of other means and/or structures for performing the functions and/or obtaining the results and/or one or more of the advantages described herein, and each of such variations and/or modifications is deemed to be within the scope of the present invention. More generally, those skilled in the art will readily appreciate that all parameters, dimensions, materials, and configurations described herein are meant to be exemplary and that the actual parameters, dimensions, materials, and/or configurations will depend upon the specific application or applications for which the teachings of the present invention is/are used.
    Those skilled in the art will recognize, or be able to ascertain using no more than routine experimentation, many equivalents to the specific embodiments of the invention described herein. It is, therefore, to be understood that the foregoing embodiments are presented by way of example only and that, within the scope of the appended claims and 3 0equivalents thereto, the invention may be practiced otherwise than as specifically described and claimed. The present invention is directed to each individual feature, system, apparatus, method step, and/or material, described herein. In addition, any combination of two or more such features, systems, apparatus, method steps, and/or materials, if not mutually inconsistent, is included within the scope of the present invention.
    权利要求:
    Claims (14)
    [1] 1. An apparatus (1) for contacting blood with ozone gas, said apparatus comprising: an ozonation chamber (2), a blood flow inlet (2a), and a blood flow outlet (2b) wherein: said ozonation chamber (2) comprises a microporous ozone injector (3) configured for connection to a source of ozone containing gas and to inject microbubbles of ozone containing gas into a flow of blood through the ozonation chamber (2) and said ozonation chamber (2) and said ozone injector (3) are configured such that the flow of blood through blood ozonation chamber (2) entrains said microbubbles of ozone containing gas into said flow of blood.
    [2] 2. The apparatus of claim 1, wherein the apparatus further comprises means for cooling a blood flow entering said ozonation chamber (2) to a temperature of less than 12°C.
    [3] 3. The apparatus of claim 1 or 2, wherein said microporous ozone injector (3) has a uniform mean pore size of less than 2Em.
    [4] 4. The apparatus of any of claims 1, 2, or 3, wherein said microporous ozone injector (3) comprises a sintered stainless steel or a sintered ceramic.
    [5] 5. The apparatus of any preceding claim, wherein said ozonation chamber (2) is shaped to provide a laminar blood flow around the ozone injector (3).
    [6] 6. A system for ozonating blood comprising the apparatus of any of claims 1-4 and further comprising a pumping means (10) for pumping blood through said apparatus and as source of ozone containing gas (4) fluidically coupled to said ozone injector (3).
    [7] 7. The system of claim 6, and further comprising a means for cooling a blood flow entering said apparatus (1) to a temperature of less than 12°C and/or a means for warming a blood flow exiting said apparatus (1).
    [8] 8. A method for contacting blood with ozone, said method comprising: receiving a flow of blood (301) into an ozonation apparatus; injecting microbubbles of an ozone containing gas (303) into said flow of blood; and delivering the ozonated blood from the apparatus (305) wherein: 11 the blood is at a temperature of less than 12°C during the injecting of ozone (303) and the microbubbles have a mean diameter of less than Elm.
    [9] 9. The method of claim 8, wherein said ozone containing gas comprises less than grams of ozone per cubic meter or wherein said ozone containing gas comprises 5% to 20% ozone by weight and 90% oxygen by weight.
    [10] 10. The method of claim 8 or 9, wherein said flow of blood during said injecting (303) is from about 0.1 Liters/hour to about 10 Liters/hour and a flow rate of said ozone containing gas about 0.01 Liter per hour to about 1 Liter per hour.
    [11] 11. The method of any of claims 8-10, and further comprising cooling said flow blood to a temperature of less than12°C before said receiving of said blood flow (301).
    [12] 12. The method of any of claims 8-11, wherein said microbubbles dissolve completely in said flow of blood less than 10 seconds after said injecting (303).
    [13] 13. The method of any of claims 8-12, wherein said ozone containing gas is injected at a pressure of less than 1 bar.
    [14] 14. The method of any of claims 8-13, wherein a flow rate of blood, an injection pressure of ozone containing gas, and/or a flow rate of ozone containing gas is/are adjusted to prevent or minimize a coalescence of microbubbles during said injecting (303). 13 Drawings 12 se...e....W.,..e. se....W., ...W.,.
    类似技术:
    公开号 | 公开日 | 专利标题
    US7011790B2|2006-03-14|Non-thermal disinfection of biological fluids using non-thermal plasma
    JP4658054B2|2011-03-23|Apparatus and method for sterilizing surfaces
    US20030232114A1|2003-12-18|Method for liquid enrichment with oxygen and applications of enriched liquids
    US20170080143A1|2017-03-23|Modular Extracorporeal Systems and Methods for Treating Blood-Borne Diseases
    WO2004062710A3|2004-10-21|Batch filtration system for preparation of sterile replacement fluid for renal therapy
    WO2000038758A1|2000-07-06|Use of a selective membrane in a biomedical device for the extracorporeal treatment of blood and other organic fluids
    CN2865701Y|2007-02-07|High-pressure ozone blood purifying device
    US20200276382A1|2020-09-03|Apparatus And Method For Contacting Blood With Ozone
    US20030118473A1|2003-06-26|Method and apparatus for ozone decontamination of biological liquids
    US7220236B2|2007-05-22|Method for eliminating HIV in human blood and a device for treating AIDS with non-pharmacotherapy
    US20130236358A1|2013-09-12|System and method for virus inactivation
    WO2004007066A1|2004-01-22|Non-thermal disinfection of biological fluids using non-thermal plasma
    US20160008525A1|2016-01-14|Hyperoxygenation/Hyperthermia Treatment Apparatus
    CN202459574U|2012-10-03|Infusion device
    CN215460746U|2022-01-11|Extracorporeal circulation treatment equipment
    EP3500317B1|2022-02-23|Peritoneal dialysis system and methods
    JP2013236928A|2013-11-28|Sterilization device and sterilization method
    US20030073945A1|2003-04-17|Ozone hemodiafiltration device
    JP2017529237A5|2018-10-25|
    Song et al.2011|Development and test of nutrient solution disinfection machine by combining UV with ozone
    JP3085300U|2002-04-26|Hemodiafiltration device that injects ozone into the human body
    CN111760121A|2020-10-13|Disposable tri-oxygen gas injection therapeutic apparatus
    CN104984435A|2015-10-21|Infusion tube capable of preventing blood backflow
    CN201006133Y|2008-01-16|Phthisis disease physiotherapy machine
    CN113350598A|2021-09-07|Extracorporeal circulation treatment apparatus
    同族专利:
    公开号 | 公开日
    CA2967307A1|2016-03-24|
    JP2017529237A|2017-10-05|
    SE541036C2|2019-03-12|
    WO2016043649A1|2016-03-24|
    EP3193948A1|2017-07-26|
    EP3193948A4|2018-06-20|
    CN107073149A|2017-08-18|
    US20170274133A1|2017-09-28|
    US20200276382A1|2020-09-03|
    JP6979357B2|2021-12-15|
    JP2021176566A|2021-11-11|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    DE3906034C1|1989-02-27|1990-09-27|Dr. J. Haensler Gmbh, 7557 Iffezheim, De|
    GB9424913D0|1994-12-09|1995-02-08|Lifetech Corp|Enhancement of treatment processes|
    GB9502347D0|1995-02-07|1995-03-29|Ca Nat Research Council|Method and apparatus for inactivation of viruses in body fluids|
    WO2004041314A1|2002-11-04|2004-05-21|Ashland Inc.|Device and process for treating a liquid medium using ultrasound in preventing the growth of hyperproliferative or infected cells|
    US5811014A|1996-11-12|1998-09-22|Sanitrol Systems, Inc.|Hazardous flowable waste sanitizing and remediating process and apparatus|
    JPH11217856A|1997-07-10|1999-08-10|（有）レーベン|Washing method of feed water pipeline, ozone-containing bubble generator used therein, and adapter for injecting ozone-containing bubble|
    IT1304503B1|1998-12-24|2001-03-19|In Te C S R L|USE OF A SELECTIVE MEMBRANE IN A BIOMEDICAL DEVICE FOR THE EXTRA-BODY TREATMENT OF BLOOD AND OTHER ORGANIC LIQUIDS.|
    US6251289B1|1999-06-03|2001-06-26|Grt, Inc.|Treatment of contaminated liquids with oxidizing gases and liquids|
    JP2001340847A|2000-06-01|2001-12-11|Canon Inc|Aeration/separation apparatus for removing/separating algae, green algae, and red tide plankton|
    US20030118473A1|2001-11-02|2003-06-26|Sunnen Gerard V.|Method and apparatus for ozone decontamination of biological liquids|
    JP2004057703A|2002-07-31|2004-02-26|L'air Liquide Sa Pour L'etude & L'exploitation Des Procedes Georges Claude|Waste liquid treatment device of hemodialysis unit|
    US7931816B2|2004-12-29|2011-04-26|Acos Llc|Method, apparatus and systems for treating contaminants in a waste fluid|
    US20120228396A1|2004-05-25|2012-09-13|Gregory Scott Osborn|System and Method for Optimizing the Dissolution of a Gas in a Liquid|
    CN2865701Y|2005-09-04|2007-02-07|郭罕斌|High-pressure ozone blood purifying device|
    CN1939545A|2005-09-30|2007-04-04|郭罕斌|High-pressure ozone blood purifier and purification|
    CA2542673A1|2006-04-10|2007-10-10|Peter Klaptchuk|Method and apparatus for pathogenic and chemical reduction in fluid waste|
    SE530656C2|2006-11-30|2008-07-29|Land & Sjoe Food Technology Ab|Ozone treatment of liquid foods|
    US8246564B2|2008-12-04|2012-08-21|Therox, Inc.|System for enriching a bodily fluid with a gas having automated priming capabilities|
    WO2013082717A1|2011-12-06|2013-06-13|Bachellier Carl Roy|Improved impeller apparatus and dispersion method|
    FR2998486B1|2012-11-28|2014-11-21|Alfaa France|DEVICE FOR TREATING FLUID|
    US20160008525A1|2014-07-11|2016-01-14|Jerry C Elliot|Hyperoxygenation/Hyperthermia Treatment Apparatus|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    SE1451072A|SE541036C2|2014-09-15|2014-09-15|Apparatus and system for ozonating blood, and method for ozonating blood prior to storage|SE1451072A| SE541036C2|2014-09-15|2014-09-15|Apparatus and system for ozonating blood, and method for ozonating blood prior to storage|
    CN201580049555.8A| CN107073149A|2014-09-15|2015-09-15|By the apparatus and method of blood and ozone contact|
    JP2017534513A| JP6979357B2|2014-09-15|2015-09-15|Devices and methods for bringing blood into contact with ozone|
    EP15842571.0A| EP3193948A4|2014-09-15|2015-09-15|Apparatus and method for contacting blood with ozone|
    US15/511,194| US20170274133A1|2014-09-15|2015-09-15|Apparatus and method for contacting blood with ozone|
    PCT/SE2015/050964| WO2016043649A1|2014-09-15|2015-09-15|Apparatus and method for contacting blood with ozone|
    CA2967307A| CA2967307A1|2014-09-15|2015-09-15|Apparatus and method for contacting blood with ozone|
    US16/815,997| US20200276382A1|2014-09-15|2020-03-11|Apparatus And Method For Contacting Blood With Ozone|
    JP2021122880A| JP2021176566A|2014-09-15|2021-07-28|Device and method for bringing blood into contact with ozone|
    [返回顶部]